HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sensodyne ProNamel TV Ad Claim's Accuracy Slips Through Cracks

Executive Summary

NAD finds from P&G challenge that Glaxo's US consumer health business provided no evidence to support express and implied claims conveyed in two TV ads featuring animated image of a tooth surface lined with deep and narrow crevices that Sensodyne ProNamel Intensive Enamel Repair fills and heals cracked enamel.

You may also be interested in...



Sonicare 'Charging Case' Comparison To Oral-B Loses Spark In Ad Review Appeal

Council of Better Business Bureaus appeals board agrees with all but one recommendation NAD made in review of claims for Philips' Sonicare DiamondClean power toothbrush challenged by P&G. In appeal by both firms, panel disagreed with investigative arm on comparative claim about toothbrush travel cases.

ACT Dry Mouth 'Immediate,' 'Moisturizing,' 'Lubricating' Claims OK In Review Appeal

Council of Better Business Bureaus' advertising review appeals panel says Sanofi didn't support claiming ACT Dry Mouth Lozenges "are uniquely formulated to stimulate saliva flow” because no evidence supported uniqueness. On review of initial findings from August 2018 on GSK challenge, which markets Biotene dry mouth products, panel considered appeals by both firms.

GSK Overly Squeamish About Crest Sensi-Stop Strips Claims – NAD

P&G emerges largely unscathed from a National Advertising Division dispute regarding claims for Crest Sensi-Stop Strips, which challenger GlaxoSmithKline Consumer Healthcare argued were unsupported, including the product name. NAD determined the firm’s evidence adequate to support claims of immediate relief and protection for up to one month, among other statements made in ads and on product packaging.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149556

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel